myTomorrows

Home
myTomorrows

myTomorrows is an international platform that links patients facing unmet medical needs to treatments in development worldwide.

We bridge the gap between patients who are searching for treatment options and the pharmaceutical companies who provide them At myTomorrows, we believe everyone should be able to access the treatment options which are open to them. We strive to make it easier for physicians and their patients with unmet medical needs to find, get information about, and access pre-approval medicines whenever possible. We believe that by making the process of accessing pre-approval medicines more transparent, we’ll be able to transform the lives of people all over the world. To contact us, please visit https://www.mytomorrows.com/en/get-in-contact.

14/11/2025

Living with diabetes while striving to excel at work can come with unique challenges and misunderstandings. That’s the reality for millions of people living with diabetes. 🌿

Diabetes is a condition that disrupts the body’s ability to control blood sugar. It occurs when the immune system destroys insulin-producing cells (Type 1) or when the body doesn’t make enough insulin or can’t use it effectively (Type 2). Without insulin, glucose cannot reach the cells, depriving them of the energy they need to function properly.

🔵 This 14 November, on World Diabetes Day, the theme, “Diabetes and Well-being in the Workplace” reminds us that awareness goes beyond care and treatment. It’s about empathy, inclusion, and creating environments where people with diabetes can truly thrive.

🌍 The global picture reminds us why awareness matters:
🔸 Nearly 600 million people worldwide are living with diabetes.
🔸 7 in 10 are of working age.
🔸 3 in 4 experience anxiety, depression, or other mental health challenges linked to their condition.
🔸4 in 5 face diabetes burnout, the physical and emotional exhaustion that comes from the constant effort of managing diabetes.

At myTomorrows, we believe no one should face diabetes alone - at home, or at work. 💙

👉 Because support begins with understanding, we have a dedicated resource page on type 1 diabetes to empower people with knowledge and education about this condition.

In this space, we have gathered information on symptoms, diagnosis, available treatments and ongoing research, with the goal of providing reliable resources to people living with diabetes, their loved ones, and anyone seeking to learn more.

🔗 Explore our Type 1 Diabetes Resource Page: https://eu1.hubs.ly/H0pF44d0

12/11/2025

ESMO-AI & Digital Oncology 2025 is in full swing! 🚀
From morning sessions to hallway conversations, one thing is clear: the oncology community is eager to move from AI potential to practical implementation.

☀️Tomorrow, Danny den Hamer will present “Practical AI for Trial Recruitment: Human-in-the-Loop Tools for Patients, Physicians, and Sites" at 10:30am.

The session will spark thoughtful discussions on the potential of AI to enhance recruitment strategies. By integrating automated processes with clinical expertise, the aim is to expand patient outreach, assist physicians more effectively, and generate higher-quality leads for clinical sites. Don't miss it!

➡️ At Booth #10, the dialogue continues. Come to meet Danny den Hamer, PharmD (Product Manager), Jytte Huijstee (Director Clinical Operations), and Patricia Aymerich (Senior Medical Partnership Manager) to exchange ideas on how to:

🔹Integrate AI tools seamlessly into existing site and physician workflows.
🔹 Improve patient access to clinical trials, especially for underrepresented groups.
🔹 Build trust in digital solutions through transparency and collaboration.

It’s inspiring to see the momentum building around these topics - not just in theory, but in practical steps being taken across the oncology ecosystem.💚

11/11/2025

Our next chapter: bringing tomorrow’s treatments closer to patients today

We’re excited to share some incredible news with our community.

myTomorrows has secured a €25 million growth investment from Avego Healthcare Capital — a huge step forward in our mission to make access to emerging treatments faster, fairer, and truly global.

From our early beginnings in Amsterdam 13 years ago, to helping patients and physicians in over 134 countries, we’ve always been guided by one belief:
every patient deserves the chance to explore every possible treatment option.

With this new investment, we’ll be able to:

Expand our support for patients and physicians around the world

Improve our technology to find pre-approval treatments faster

Strengthen partnerships with BioPharma to bring new therapies to more people

This milestone isn’t just about growth — it’s about continuing to stand beside patients and families who are searching for options when time matters most.

Read more about our growth story here: https://eu1.hubs.ly/H0pvxyP0

🎥 Watch our new company video to hear from our team in their own words.

We’re growing fast. Keep an eye on our careers page for new opportunities to join our global team: https://mytomorrows.com/about-mytomorrows/careers/

29/10/2025

Patient recruitment remains one of the greatest barriers to clinical trial success - creating a gap between the industry’s investment in research and the ability to deliver studies efficiently, on time, and with reliable outcomes.

Next week, the Patient Recruitment & Retention Summit in Boston will bring together BioPharma leaders and clinical sites to address this challenge - and myTomorrows is excited to join the discussion.

📅 November 4–6, 2025
📍 Boston, MA

Our Mighties Dennis Akkaya, Chief Commercial Officer, Michael Lambert, MBA, Senior Program Manager, and Michelle Angert, Patient Navigator, will host a fireside chat on ‘Key considerations for an effective Patient Recruitment Program’ November 5th from 12:00 to 12:30 PM.

You will learn:
✔️Key steps for successfully launching a patient recruitment program in ultra-rare diseases.
✔️How a comprehensive recruitment funnel supports Pharma in optimizing patient engagement and study performance.
✔️How Patient Navigators collaborate with key stakeholders to enhance enrollment and retention.

💬 Want to continue the conversation? Come meet us to discuss:
🔹Smarter strategies to engage underrepresented or hard-to-reach populations
🔹 Operational models that put accessibility and efficiency first
🔹 Innovative technologies that make trials more resilient from recruitment to retention

👉 If you’ll be at the Summit, let’s connect. We’d love to exchange ideas and explore potential collaborations.

28/10/2025

This week, grey becomes more than a colour: it stands for strength, support, and solidarity. 🩶

At myTomorrows, we’re proud to once again stand with our partner brainstrust in championing the campaign: a UK movement dedicated to raising awareness of brain tumours and showing everyone affected that they’re not alone. 🧠

Every day, around 30 people in the UK hear the life-changing words, “You have a brain tumour”. For many, the journey ahead may be filled with questions and uncertainty. That’s where brainstrust steps in - offering coaching, resources, and care to help people feel less afraid, less alone, and more in control.

🤝 Our partnership with brainstrust reflects a shared commitment to empower the brain tumour community. At myTomorrows we ensure that patients and healthcare professionals have access to reliable up-to-date information regarding clinical trial participation.

🗓️ During UK Brain Tumour Awareness Week -25th October to 1st November 2025, the Wear Grey campaign will shine a light on the experiences of people living with a brain tumour, sharing their stories and highlighting initiatives that foster community connection.

🌐 Join us in raising awareness and standing in solidarity with the brain tumour community.

Find out more about the campaign here 👉 https://eu1.hubs.ly/H0p9F3Y0

23/10/2025

📢 Registration Reminder: Don’t Miss Out

The 2nd Pre-Approval Access to Medicines in Asia-Pacific Conference takes place 10–11 March 2026 at the PARKROYAL on Beach Road, Singapore. https://eu1.hubs.ly/H0p35xx0

Across the region, patients with life-threatening conditions face barriers in navigating early access pathways. Fragmented regulations, operational complexity, and resource constraints remain important challenges in advancing pre-approval access. This conference brings together biopharma, regulators, policymakers, and patient advocates to turn these barriers into solutions - not in theory, but in practice.

Through keynotes, panels, and case studies, attendees will gain hands-on strategies to:
🔹 Translate ethical frameworks into actionable processes
🔹 Drive operational excellence in program delivery
🔹 Navigate diverse regulatory requirements across APAC
🔹 Build effective, collaborative stakeholder workflows

Beyond the sessions, the conference offers extensive networking opportunities with thought leaders and peers - enabling participants to exchange insights, forge partnerships, and help shape the future of patient access in the region.

📸 Below are highlights from the inaugural 2025 edition - where the dialogue began. The event brought together leaders from across the APAC region for presentations, discussions, and the exchange of ideas that set the stage for meaningful progress. In 2026, we will build on that momentum with a sharper focus on real-world implementation.

⏳ Early bird rates available until 28 November 2025⏳

👉 Secure your place today: https://eu1.hubs.ly/H0p35xx0

21/10/2025

📢 Attention job seekers! Kickstart your week with our latest job vacancies.

We are looking for two people to help deliver a whole new approach to enabling earlier access to all possible treatment options, making a on many lives.

Share our job openings with your network who may be interested, and they could join a fast-growing company of 80+ people, with 30 nationalities, offering great benefits in Amsterdam.

✔️Senior DevOps Engineer: https://eu1.hubs.ly/H0n_0Tm0
✔️Regulatory Affairs Pharmacovigilance Manager: https://eu1.hubs.ly/H0n_08P0

👉 Our full list: https://eu1.hubs.ly/H0n_1jg0

15/10/2025

SCOPE Europe 2025 is buzzing here in Barcelona! 🚀

It’s inspiring to see leaders from BioPharma, biotech, CROs, sites, and patient groups all coming together with one mission: to rethink how we plan, run, and deliver clinical trials. The exchange of ideas has been incredible: proof that innovation truly happens when multiple perspectives converge.

Yesterday, our colleagues Danny den Hamer and Christa Reefman joined that conversation on stage, sharing how a multi-stakeholder approach can transform patient recruitment in Europe. They highlighted:

✔️ How platform models cut through complexity to accelerate recruitment
✔️ The impact of Patient Navigators in enabling cross-border referrals and expanding trial access
✔️Ways biopharma can partner with CROs to strengthen referral networks and improve protocol amendment cycles

🙌 Couldn’t join the session? Stop by Booth #13 to continue the conversation! Meet the full Mighty team:

🔹Karlijn Doorn, PhD, Head of Partnerships & Customer Success
🔹Danny den Hamer, PharmD, Senior Community Development Manager
🔹Christa Reefman, Senior Program Manager
🔹Theo Cantero, Patient Navigator

We’d love to share more and hear your perspective on the future of patient recruitment.
👉 Book a meeting with us: https://eu1.hubs.ly/H0nR-930

14/10/2025

🌐 The ALS community has worked tirelessly to improve access to clinical trials and expanded access programs for people living with ALS. Through decades of relentless advocacy for patient-centered trial designs, regulatory prioritization, and global equity in access, the ALS community has helped ensure that patients are truly supported, and relevant information about treatment opportunities is available to those who need them most.

At myTomorrows, we recognize the profound impact of this advocacy and aim to work side by side to help patients know their options. Earlier this year, we were invited to present a poster at both the ALS Nexus Conference and the NEALS Annual Meeting, reflecting our commitment to support patients with information about ALS research opportunities.

📊 The poster demonstrated valuable insights from the first year of our collaboration with the The ALS Association, where we analyzed more than 460 patient inquiries throughout their entire journey, from trial exploration to consideration and to potential clinical trial participation.

Our presence in the neuromuscular disease space, including with ALS community is continuously growing. We’ve learnt that in order to deliver meaningful progress, it is critical for all stakeholders to be connected and engaged - from patients, caregivers, research sites, advocacy groups and BioPharma partners.

📈 To date, we have supported over 120 clinical sites in the US within the Neuromuscular and Neurodegenerative space.
With the launch of our site referral platform and direct patient navigator initiatives, we are gaining valuable insights and creating ways to support patients in exploring clinical trial options in collaboration with their healthcare providers.

👉 Read more about how myTomorrows is striving to accelerate ALS clinical trial recruitment in the U.S. https://eu1.hubs.ly/H0nQ3_c0
➡️ You can find out more about The ALS Association and myTomorrows partnership here: https://eu1.hubs.ly/H0nQ60d0

13/10/2025

We’re gearing up for SCOPE Europe 2025 in Barcelona this week! 🚀

From October 13–15, the InterContinental Barcelona will host Europe’s leading clinical operations meeting, bringing together 700+ senior leaders from Pharma, Biotech, CROs, technology providers, academia, and patient groups. Across six conferences, three workshops, and 50+ exhibitors, participants will explore the latest in clinical trial design, innovation, and ex*****on.

🎤 On Tuesday, October 14 at 10:40 AM, don’t miss our session with Danny den Hamer and Christa Reefman: “Patient Recruitment – A Multi-Stakeholder Approach for EU Program Success”

✔️ Learn how a platform model streamlines recruitment and engagement across stakeholders.
✔️ Discover the impact of Patient Navigators in enabling cross-border referrals and improving trial access.
✔️ Explore how biopharma can augment CRO workflows to build referral networks and improve protocol amendment cycle.

👉 Do you want to continue the conversation? Meet the full Mighty team at Booth #13:
🔹Karlijn Doorn, PhD, Head of Partnerships & Customer Success
🔹Danny den Hamer, PharmD, Senior Community Development Manager
🔹Christa Reefman, Senior Program Manager
🔹Theo Cantero, Patient Navigator

📅 Or book a meeting with us: https://eu1.hubs.ly/H0nLy8b0
We’d love to showcase how our patient recruitment services support biopharma companies and share how we collaborate with CROs and sites to accelerate trial success.

10/10/2025

AI is moving at record speed - and this week, it was on full display at OpenAI DevDay 2025 in San Francisco! 🚀

Our AI Product Manager and developer, Danny den Hamer, attended alongside other developers, thought leaders and OpenAI employees all eager to build the future using AI. The atmosphere was buzzing with innovation, and one thing was clear: in just a few years, AI has evolved from simple word prediction tools to sophisticated agents capable of handling complex tasks throughout diverse industries.

👉 Danny summed it up perfectly: “Intelligence is no longer the limiting factor for AI adoption across sectors.” Yet, when it comes to healthcare, intelligence must go hand-in-hand with compliance, security, privacy, trust, and transparency.

That’s why at myTomorrows, we’ve built these foundations into our AI-powered platform and new Matching API. With ISO-27001 certification and GDPR, HIPAA, and SOC 2 compliance, healthcare professionals can securely:

✔️ Search and pre-screen patients for clinical trials using AI
✔️ Refer to, and collaborate with sites efficiently
✔️ Access clear, structured information on Expanded Access Programs when clinical trials are not available for a specific patient case
✔️ Manage and track patient information with confidence

💡 Today, our AI-powered platform is already proving the impact:
✔️Up to 98% accuracy in eligibility pre-screening
✔️90% less workload for HCPs looking for clinical trial options for their patients
✔️ Matched 15,000+ patients to clinical trials and Expanded Access Programs (EAPs) across 128 countries to date

✨ Events like DevDay serve as a powerful reminder of why we innovate: not only to push technology forward, but also to ensure it benefits doctors, researchers and patients who need it the most.

🔬At myTomorrows, we’re continuously looking at opportunities for deploying AI. Our engineering team has widely adopted AI coding tools to improve our product even faster, and we will be launching more AI-supported features soon.

10/10/2025

🌍 Today is World Mental Health Day.

This year, we are reflecting on the mental health of people living with serious conditions.

For many, the emotional weight of a diagnosis can be just as heavy as the medical one. Between doctor’s visits, test results, and everyday responsibilities, it’s easy to feel overwhelmed. This is especially true when the standard course of treatments have been exhausted.

That’s why our Patient Navigators place listening and understanding at the heart of every conversation. In a 15–30-minute call in your preferred language, our team takes the time to understand your situation and needs. Every conversation is:

✅ Compassionate and confidential
✅ Flexible to your schedule and needs
✅ Focused on helping you feel supported, not pressured

We are here to support you every step of your clinical research journey, including helping you discover and access clinical trials that may be suitable for you.

On World Mental Health Day, we want to remind everyone: you don’t have to face your journey alone. 💙

Address

Website

https://myTomorrows.com/

Alerts

Be the first to know and let us send you an email when myTomorrows posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to myTomorrows:

Shortcuts

Want your practice to be the top-listed Clinic?

Country:

City: